Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Valar Labs

News headline image
Valar Labs Publishes Pivotal Study in Journal of Clinical Oncology Validating AI to Predict Chemotherapy Response for Pancreatic Cancer Patients
From Valar Labs
Via Business Wire
News headline image
Valar Labs Announces Strategic Partnership with PathNet Lab to Deliver AI-Driven Bladder Cancer Insights Nationwide
From Valar Labs
Via Business Wire
News headline image
Acupath and Valar Labs Announce Strategic Partnership to Deliver Vesta, AI-Powered Diagnostic Tests for Non–Muscle Invasive Bladder Cancer
From Valar Labs
Via Business Wire
News headline image
Valar Labs’ CHAI Biomarkers Validated in New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
From Valar Labs
Via Business Wire
News headline image
Valar Labs Announces $22 Million Series A to Advance Vesta, First AI Diagnostic Test to Predict Treatment Response in Bladder Cancer, and Catalyze Expansion in Other Cancers
From Valar Labs
Via Business Wire
News headline image
Valar Labs Announces Validation of First Histology-based Test to Predict Response to BCG in Bladder Cancer
From Valar Labs
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.